AN2 Therapeutics, Inc. ( (ANTX)) has shared an announcement. AN2 Therapeutics has promoted its Chief Legal Counsel, Joshua Eizen, to the roles of Chief Legal Officer and Chief Operating Officer, ...
MENLO PARK, Calif. - AN2 Therapeutics, Inc. (NASDAQ:ANTX), a biopharmaceutical company specializing in boron-based small molecule therapeutics, has announced the extension of a research grant from ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mineralys Therapeutics, Inc. (MLYS – ...
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its ...
MENLO PARK, Calif. - AN2 Therapeutics, Inc. (NASDAQ:ANTX), a biopharmaceutical company specializing in boron-based small molecule therapeutics, has announced the extension of a research grant from the ...
If ultimately fully funded, the MPC2SC Program will start by identifying 10 students at the community college during their ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
GlobalData on MSN14d
Spero’s stock slides after antibiotic flops in Phase II trialThe company has also laid off 39% of its staff as it discontinued the development of SPR720 for non-tuberculous mycobacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback